News & Analysis on Clinical Trial Services & Contract Research And Development
Update
As biotech funding saw one of the strongest quarters since 2004, Covance CEO Joe Herring predicts that the CRO industry is poised see an even higher percentage of biopharma R&D to be outsourced.
Clondalkin Pharma & Healthcare has been fined £12,000 for safety failings after a worker was injured by unguarded machinery at the contract packaging and printing firm’s facility in Cambridgeshire, UK.
The Form 483 from the US FDA cited Chicago-based Morton Grove Pharmaceuticals, which was acquired by Wockhardt in October 2007, for 12 different observations.
Microscopic worms exposed to the diabetes medication metformin live longer because the drug makes them produce more free radicals according to a new study that has implications for human health and advocates of “anti-aging” antioxidants.
Provence Technologies, a French chemical developer, has acquired the active pharmaceutical ingredient (API) maker Synprosis, a specialist in synthesising long-chain peptides.
A UK software maker has launched an iPad tool it says ends the need for CROs (clinical research organisations) to hire trained neuropsychologists to measure drugs’ effects on the brain.
As WuXi talks of a surge in its outsourced manufacturing services, the company has begun offering high-potency active pharmaceutical ingredients (HPAPIs).